137 related articles for article (PubMed ID: 19065655)
1. Dopamine D2 receptor polymorphisms and adenoma recurrence in the Polyp Prevention Trial.
Murphy G; Cross AJ; Sansbury LS; Bergen A; Laiyemo AO; Albert PS; Wang Z; Yu B; Lehman T; Kalidindi A; Modali R; Schatzkin A; Lanza E
Int J Cancer; 2009 May; 124(9):2148-51. PubMed ID: 19065655
[TBL] [Abstract][Full Text] [Related]
2. Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention Trial.
Murphy G; Sansbury LB; Cross AJ; Stolzenberg-Solomon R; Laiyemo A; Albert PS; Wang Z; Schatzkin A; Lehman T; Kalidindi A; Modali R; Lanza E
Cancer Causes Control; 2008 Sep; 19(7):751-8. PubMed ID: 18322814
[TBL] [Abstract][Full Text] [Related]
3. Dopamine receptor D2 genetic variations is associated with the risk and clinicopathological variables of urothelial cell carcinoma in a Taiwanese population.
Tung MC; Wen YC; Wang SS; Lin YW; Liu YC; Yang SF; Chien MH
Int J Med Sci; 2018; 15(11):1187-1193. PubMed ID: 30123056
[TBL] [Abstract][Full Text] [Related]
4. Dairy products, polymorphisms in the vitamin D receptor gene and colorectal adenoma recurrence.
Hubner RA; Muir KR; Liu JF; Logan RF; Grainge MJ; Houlston RS;
Int J Cancer; 2008 Aug; 123(3):586-93. PubMed ID: 18470879
[TBL] [Abstract][Full Text] [Related]
5. Do interleukin polymorphisms play a role in the prevention of colorectal adenoma recurrence by dietary flavonols?
Bobe G; Murphy G; Albert PS; Sansbury LB; Young MR; Lanza E; Schatzkin A; Colburn NH; Cross AJ
Eur J Cancer Prev; 2011 Mar; 20(2):86-95. PubMed ID: 21160427
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.
Barry EL; Sansbury LB; Grau MV; Ali IU; Tsang S; Munroe DJ; Ahnen DJ; Sandler RS; Saibil F; Gui J; Bresalier RS; McKeown-Eyssen GE; Burke C; Baron JA
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2726-33. PubMed ID: 19755647
[TBL] [Abstract][Full Text] [Related]
7. Polynucleotide kinase 3' phosphatase variant, dietary variables and risk of adenoma recurrence in the Polyp Prevention Trial.
Murphy G; Sansbury LS; Bergen AW; Wang Z; Schatzkin A; Lehman T; Kalidindi A; Modali R; Lanza E
Eur J Cancer Prev; 2008 Jun; 17(3):287-90. PubMed ID: 18414202
[TBL] [Abstract][Full Text] [Related]
8. Epistatic effect of Ankyrin repeat and kinase domain containing 1 - Dopamine receptor D2 and catechol-o-methyltransferase single nucleotide polymorphisms on the risk for hazardous use of alcohol in Lithuanian population.
Kaminskaite M; Jokubka R; Janaviciute J; Lelyte I; Sinkariova L; Pranckeviciene A; Borutaite V; Bunevicius A
Gene; 2021 Jan; 765():145107. PubMed ID: 32889058
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial.
Sansbury LB; Bergen AW; Wanke KL; Yu B; Caporaso NE; Chatterjee N; Ratnasinghe L; Schatzkin A; Lehman TA; Kalidindi A; Modali R; Lanza E
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):494-501. PubMed ID: 16537707
[TBL] [Abstract][Full Text] [Related]
10. MTHFR genotype and colorectal adenoma recurrence: data from a double-blind placebo-controlled clinical trial.
Levine AJ; Wallace K; Tsang S; Haile RW; Saibil F; Ahnen D; Cole BF; Barry EL; Munroe DJ; Ali IU; Ueland P; Baron JA
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2409-15. PubMed ID: 18768511
[TBL] [Abstract][Full Text] [Related]
11. Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study.
Mitrou PN; Watson MA; Loktionov AS; Cardwell C; Gunter MJ; Atkin WS; Macklin CP; Cecil T; Bishop DT; Primrose J; Bingham SA
Carcinogenesis; 2007 Apr; 28(4):875-82. PubMed ID: 17082176
[TBL] [Abstract][Full Text] [Related]
12. Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial.
Bobe G; Sansbury LB; Albert PS; Cross AJ; Kahle L; Ashby J; Slattery ML; Caan B; Paskett E; Iber F; Kikendall JW; Lance P; Daston C; Marshall JR; Schatzkin A; Lanza E
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1344-53. PubMed ID: 18559549
[TBL] [Abstract][Full Text] [Related]
13. CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.
Barry EL; Poole EM; Baron JA; Makar KW; Mott LA; Sandler RS; Ahnen DJ; Bresalier RS; McKeown-Eyssen GE; Ulrich CM
Cancer Causes Control; 2013 Jan; 24(1):47-54. PubMed ID: 23081681
[TBL] [Abstract][Full Text] [Related]
14. Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation.
Figueiredo JC; Levine AJ; Grau MV; Midttun O; Ueland PM; Ahnen DJ; Barry EL; Tsang S; Munroe D; Ali I; Haile RW; Sandler RS; Baron JA
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2136-45. PubMed ID: 18708408
[TBL] [Abstract][Full Text] [Related]
15. Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial.
Bobe G; Murphy G; Rogers CJ; Hance KW; Albert PS; Laiyemo AO; Sansbury LB; Lanza E; Schatzkin A; Cross AJ
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1441-52. PubMed ID: 20501764
[TBL] [Abstract][Full Text] [Related]
16. Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas.
Giovannucci E; Chen J; Smith-Warner SA; Rimm EB; Fuchs CS; Palomeque C; Willett WC; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):970-9. PubMed ID: 14578131
[TBL] [Abstract][Full Text] [Related]
17. Dietary factors and biomarkers involved in the methylenetetrahydrofolate reductase genotype-colorectal adenoma pathway.
MartÃnez ME; Thompson P; Jacobs ET; Giovannucci E; Jiang R; Klimecki W; Alberts DS
Gastroenterology; 2006 Dec; 131(6):1706-16. PubMed ID: 17087956
[TBL] [Abstract][Full Text] [Related]
18. DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Morton LM; Wang SS; Bergen AW; Chatterjee N; Kvale P; Welch R; Yeager M; Hayes RB; Chanock SJ; Caporaso NE
Pharmacogenet Genomics; 2006 Dec; 16(12):901-10. PubMed ID: 17108814
[TBL] [Abstract][Full Text] [Related]
19. Folate metabolism polymorphisms influence risk of colorectal adenoma recurrence.
Hubner RA; Muir KR; Liu JF; Sellick GS; Logan RF; Grainge M; Armitage N; Chau I; Houlston RS
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1607-13. PubMed ID: 16985020
[TBL] [Abstract][Full Text] [Related]
20. Association between DRD2 (rs1799732 and rs1801028) and ANKK1 (rs1800497) polymorphisms and schizophrenia: a meta-analysis.
Yao J; Pan YQ; Ding M; Pang H; Wang BJ
Am J Med Genet B Neuropsychiatr Genet; 2015 Jan; 168B(1):1-13. PubMed ID: 25504812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
